Article
Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.
Journal of acquired immune deficiency syndromes (1999) - 1 Jan 2011
Ruel Theodore D, Kamya Moses R, Li Pelin, Pasutti William, Charlebois Edwin D, Liegler Teri, Dorsey Grant, Rosenthal Philip J, Havlir Diane V, Wong Joseph K, Achan Jane
Abstract excerpt
BACKGROUND: Without virologic testing, HIV-infected African children starting antiretroviral (ARV) therapy are at risk for undetected virologic failure and the development of ARV resistance. We sought to determine the prevalence of early virologic failure (EVF), to characterize the evolution of ARV-resistance mutations and to predict the impact on second-line therapy. METHODS: The prevalence of EVF (HIV RNA >400...
Topics
Join the communities discussing this publication.
